HEMANT SURGICAL INDUSTRIES LIMITED

Scale -

Revenue is 232 Rs Cr; Annual Growth is 117 %; 5 Year CAGR is 117 %
Ebitda is 29.1 Rs Cr; Annual Growth is 106 %; 5 Year CAGR is 106 %
PBT is 129 Rs Cr; Annual Growth is 135 %; in Top Quartile; 5 Year CAGR is 135 %
PAT is 19.19 Rs Cr; Annual Growth is 139 %; 5 Year CAGR is 139 %
Quarterly Revenue is 785 Rs Cr; Continuous Growth over 3 Quarters; in Top Quartile

Profitability -

PAT Margin is 8.27 %; 5 Year CAGR is 10 %

Return -

ROCE is 19.51 %; Annual Growth is 34 %; 5 Year CAGR is 34 %
ROA is 6.99 %; Annual Growth is 29 %; 5 Year CAGR is 29 %

Efficiency -

Quick Ratio is 1; Annual Growth is 33 %; 5 Year CAGR is 33 %; in Bottom Quartile

Operating cash flow is -32.04 Rs Cr; Annual Decline is -462 %; in Bottom Quartile
Current Ratio is 1.45; in Bottom Quartile

Solvancy -

Long term Debt is 2.88 Rs Cr; Annual Decline is -88 %; 5 Year CAGR is -88 %; in Top Quartile
Contingent Liabilities is 0 Rs Cr; Annual Decline is -100 %
Debt/Equity is 0.36; 5 Year CAGR is -27 %; in Top Quartile

Total Debt is 49.66 Rs Cr; Annual Growth is 60 %; in Top Quartile; 5 Year CAGR is 60 %

Quality -

Change in Inventories/Total Expenses is -4 %; in Bottom Quartile; Annual Growth is 76 %
Other Expenses/Total Expenses is 9 %; in Bottom Quartile
Current Tax/PAT is 28 %; 5 Year CAGR is -18 %

Operating cashflow/ebitda is -110 %; Annual Decline is -276 %; in Bottom Quartile
Operating cashflow/PAT is -167 %; Annual Decline is -252 %; in Bottom Quartile
Exceptional Items/PBT is 0 %; in Top Quartile

Quarterly Results- overall

Annual Results- Scale

Annual Results- Liquidity

Annual Results- Profitability/Return

Annual Results- Valuation

External Ecosystem

Sector

Major Subsidiaries/Associates

Key Clients

Products

Products

Product details

Operations

Capacity/ Production

Key Facilities

Key Certifications

Raw materials

Search: